- Solar storm could impact US hurricane recovery efforts: agency
- Delta eyes Election Day travel pullback as profits climb
- Florida battered by hurricane, floods but spared 'worst-case scenario'
- UK's William and Kate in first joint public engagement since cancer treatment
- Over 200 women in legal talks with Harrods over Fayed abuse claims
- A very stiff breeze: BBC says sorry for 20,000 kph wind forecast
- Musk finally unveiling his long-promised robotaxi
- London's Frieze art fair goes potty for ceramics
- US, Europe stocks fall on US inflation data
- US consumer inflation eases to 2.4% in September
- Hurricane Milton tornadoes kill four in Florida amid rescue efforts
- South Korea's Han Kang wins literature Nobel
- Ikea posts fall in annual sales after lowering prices
- Stock markets diverge, oil gains after China rebounds
- World can't 'waste time' trading climate change blame: COP29 hosts
- South Korean same-sex couples make push for marriage equality
- Mumbai declares day of mourning for Indian industrialist Ratan Tata
- 7-Eleven owner restructures to fight takeover
- Sri Lanka recovering faster than expected: World Bank
- Hong Kong, Shanghai rally as most markets track Wall St record
- Uniqlo owner reports record annual earnings
- Hong Kong, Shanghai rally as markets track Wall St record
- Indonesia biomass drive threatens key forests: report
- Mumbai mourns Indian industrialist Ratan Tata
- China opens $71 bn 'swap facility' to boost markets
- Asian markets track Wall St record as Hong Kong, Shanghai stabilise
- 'Denying my potential': women at Japan's top university call out gender imbalance
- China's central bank says opens up $70.6 bn in liquidity to boost market
- Youth facing unprecedented wave of violence, UN envoy warns
- 'A casino in every kitchen': Brazil's online gambling craze
- Nobel chemistry winner sees engineered proteins solving tough problems
- Discord seen as online home for renegades
- US forecasts severe solar storm starting Thursday
- Ratan Tata: Indian mogul who built a global powerhouse
- One dead as storm Kirk tears through Spain, Portugal, France
- Indian business titan Ratan Tata dead at 86
- Fed minutes highlight divisions over rate cut decision
- Steve McQueen debuts new WWII film at London festival
- Nobel winners hope protein work will spur 'incredible' breakthroughs
- What are proteins again? Nobel-winning chemistry explained
- AI steps into science limelight with Nobel wins
- Overshooting 1.5C risks 'irreversible' climate impact: study
- Demis Hassabis, from chess prodigy to Nobel-winning AI pioneer
- Global stocks diverge as Chinese shares tumble
- Time runs out in Florida to flee Hurricane Milton
- Chad issues warning ahead of more devastating floods
- Creator's death no bar to new 'Dragon Ball' products
- Chinese stocks tumble on lack of fresh stimulus
- Trio wins chemistry Nobel for protein design, prediction
- Braving war: Lebanon's 'badass' airline defies odds
RBGPF | 4.03% | 63.35 | $ | |
RYCEF | 0% | 6.9 | $ | |
CMSC | 0.15% | 24.557 | $ | |
BCC | -2.88% | 138.41 | $ | |
SCS | -3.7% | 12.565 | $ | |
BTI | -0.97% | 35.14 | $ | |
AZN | -0.99% | 76.745 | $ | |
NGG | 0.14% | 65.72 | $ | |
RIO | 0.53% | 66.705 | $ | |
GSK | -2.85% | 39.125 | $ | |
RELX | -0.77% | 46.355 | $ | |
JRI | -0.1% | 13.207 | $ | |
VOD | -0.31% | 9.7 | $ | |
BCE | -1.71% | 32.75 | $ | |
BP | 0.9% | 32.27 | $ | |
CMSD | 0.27% | 24.746 | $ |
Covid infection gives similar immunity to vaccination: study
The protection against Covid-19 from being previously infected lasts at least as long as that offered by vaccination, one of the largest studies conducted on the subject said on Friday.
Ten months after getting Covid, people still had an 88 percent lower risk of reinfection, hospitalisation and death, according to the study published in the Lancet journal.
That makes this natural immunity "at least as durable, if not more so" than two doses of Pfizer or Moderna's vaccines, the study said.
The authors nevertheless emphasised that their findings should not discourage vaccination, which remains the safest way to get immunity.
The study, led by the US-based Institute for Health Metrics and Evaluation (IHME), said it was the most comprehensive analysis on how long protection lasts for the different forms of immunity.
The researchers reviewed 65 studies from 19 countries up to September 2022, meaning some covered the period when Omicron swept across the world.
Omicron proved to be more contagious than previous strains, but less severe.
People with natural immunity from a pre-Omicron variant saw their protection against reinfection wear off much more quickly for the early Omicron strains, dropping to 36 percent after 10 months, the study said.
"Vaccines continue to be important for everyone in order to protect high-risk populations such as those who are over 60 years of age and those with comorbidities," study co-author Caroline Stein of the IHME said in a statement.
The study also gives a more accurate picture of what Covid might look like in the future, as more vaccinated people are reinfected, acquiring "hybrid immunity".
"In the long run, most infections will occur in people with strong protection against severe disease because of previous infection, vaccination, or both," said Cheryl Cohen, an epidemiologist at South Africa's National Institute for Communicable Diseases.
"These results suggests that, similar to other human coronaviruses, there might be a low seasonal hospitalisation burden" associated with Covid, Cohen said in a Lancet commentary.
C.Peyronnet--CPN